VERACYTE, INC. Selling and Marketing Expense
VERACYTE, INC. (VCYT) reported Selling and Marketing Expense of $28.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-07-31
- VERACYTE, INC. selling and marketing expense for the quarter ending 2026-06-30 was $28.26M, a 11.64% increase year-over-year.
- VERACYTE, INC. selling and marketing expense for the quarter ending 2026-03-31 was $27.16M, a 11.05% increase year-over-year.
- VERACYTE, INC. selling and marketing expense for the quarter ending 2025-12-31 was $25.94M, a 4.50% increase year-over-year.
- VERACYTE, INC. selling and marketing expense for the quarter ending 2025-09-30 was $24.45M, a 8.15% increase year-over-year.
- VERACYTE, INC. selling and marketing expense for fiscal 2025 was $100.17M, a 4.96% increase from fiscal 2024.
- VERACYTE, INC. selling and marketing expense for fiscal 2024 was $95.43M, a 5.97% decline from fiscal 2023.
- VERACYTE, INC. selling and marketing expense for fiscal 2023 was $101.49M, a 4.03% increase from fiscal 2022.
- VERACYTE, INC. selling and marketing expense for fiscal 2022 was $97.56M, a 22.19% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.26M 10-Q · filed 2026-07-31 | $55.42M 10-Q · filed 2026-07-31 | $81.36M derived: sum of 3 quarters · filed 2026-07-31 | $105.81M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $27.16M 10-Q · filed 2026-05-06 | $53.10M derived: sum of 2 quarters · filed 2026-05-06 | $77.55M derived: sum of 3 quarters · filed 2026-05-06 | $102.87M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $25.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $50.40M derived: sum of 2 quarters · filed 2026-02-26 | $75.71M derived: sum of 3 quarters · filed 2026-07-31 | $100.17M 10-K · filed 2026-02-26 |
| 2025-09-30 | $24.45M 10-Q · filed 2025-11-05 | $49.77M derived: sum of 2 quarters · filed 2026-07-31 | $74.22M 10-Q · filed 2025-11-05 | $99.05M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $25.32M 10-Q · filed 2026-07-31 | $49.77M 10-Q · filed 2026-07-31 | $74.59M derived: sum of 3 quarters · filed 2026-07-31 | $97.21M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $24.45M 10-Q · filed 2026-05-06 | $49.28M derived: sum of 2 quarters · filed 2026-05-06 | $71.89M derived: sum of 3 quarters · filed 2026-05-06 | $96.11M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $24.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $47.44M derived: sum of 2 quarters · filed 2026-02-26 | $71.65M derived: sum of 3 quarters · filed 2026-02-26 | $95.43M 10-K · filed 2026-02-26 |
| 2024-09-30 | $22.61M 10-Q · filed 2025-11-05 | $46.83M derived: sum of 2 quarters · filed 2025-11-05 | $70.61M 10-Q · filed 2025-11-05 | $95.87M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $24.22M 10-Q · filed 2025-08-07 | $48.00M 10-Q · filed 2025-08-07 | $73.26M derived: sum of 3 quarters · filed 2026-02-26 | $97.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $23.78M 10-Q · filed 2025-05-08 | $49.04M derived: sum of 2 quarters · filed 2026-02-26 | $73.39M derived: sum of 3 quarters · filed 2026-02-26 | $99.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $49.60M derived: sum of 2 quarters · filed 2026-02-26 | $75.36M derived: sum of 3 quarters · filed 2026-02-26 | $101.49M 10-K · filed 2026-02-26 |
| 2023-09-30 | $24.34M 10-Q · filed 2024-11-07 | $50.10M derived: sum of 2 quarters · filed 2024-11-07 | $76.23M 10-Q · filed 2024-11-07 | $100.36M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $25.76M 10-Q · filed 2024-08-07 | $51.89M 10-Q · filed 2024-08-07 | $76.01M derived: sum of 3 quarters · filed 2025-02-28 | $101.69M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $26.13M 10-Q · filed 2024-05-08 | $50.26M derived: sum of 2 quarters · filed 2025-02-28 | $75.94M derived: sum of 3 quarters · filed 2025-02-28 | $99.94M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $24.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $49.80M derived: sum of 2 quarters · filed 2025-02-28 | $73.81M derived: sum of 3 quarters · filed 2025-02-28 | $97.56M 10-K · filed 2025-02-28 |
| 2022-09-30 | $25.68M 10-Q · filed 2023-11-08 | $49.68M derived: sum of 2 quarters · filed 2023-11-08 | $73.43M 10-Q · filed 2023-11-08 | $95.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $24.00M 10-Q · filed 2023-08-09 | $47.76M 10-Q · filed 2023-08-09 | $69.97M derived: sum of 3 quarters · filed 2024-02-29 | $91.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $23.75M 10-Q · filed 2023-05-05 | $45.97M derived: sum of 2 quarters · filed 2024-02-29 | $67.64M derived: sum of 3 quarters · filed 2024-02-29 | $87.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $22.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $43.88M derived: sum of 2 quarters · filed 2024-02-29 | $63.54M derived: sum of 3 quarters · filed 2024-02-29 | $79.84M 10-K · filed 2024-02-29 |
| 2021-09-30 | $21.67M 10-Q · filed 2022-11-03 | $41.33M derived: sum of 2 quarters · filed 2022-11-03 | $57.63M 10-Q · filed 2022-11-03 | $70.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $19.66M 10-Q · filed 2022-08-03 | $35.96M 10-Q · filed 2022-08-03 | $49.11M derived: sum of 3 quarters · filed 2023-03-01 | $60.06M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $16.30M 10-Q · filed 2022-05-04 | $29.45M derived: sum of 2 quarters · filed 2023-03-01 | $40.40M derived: sum of 3 quarters · filed 2023-03-01 | $51.10M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $24.10M derived: sum of 2 quarters · filed 2023-03-01 | $34.80M derived: sum of 3 quarters · filed 2023-03-01 | $52.39M 10-K · filed 2023-03-01 |
| 2020-09-30 | $10.96M 10-Q · filed 2021-11-09 | $21.66M derived: sum of 2 quarters · filed 2021-11-09 | $39.24M 10-Q · filed 2021-11-09 | $53.42M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $10.70M 10-Q · filed 2021-07-29 | $28.29M 10-Q · filed 2021-07-29 | $42.47M derived: sum of 3 quarters · filed 2022-02-28 | $55.56M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $17.58M 10-Q · filed 2021-05-10 | $31.77M derived: sum of 2 quarters · filed 2022-02-28 | $44.85M derived: sum of 3 quarters · filed 2022-02-28 | $58.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $14.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $27.27M derived: sum of 2 quarters · filed 2022-02-28 | $41.21M derived: sum of 3 quarters · filed 2022-02-28 | $53.69M 10-K · filed 2022-02-28 |
| 2019-09-30 | $13.09M 10-Q · filed 2020-11-02 | $27.03M derived: sum of 2 quarters · filed 2020-11-02 | $39.51M 10-Q · filed 2020-11-02 | $49.57M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $13.94M 10-Q · filed 2020-07-30 | $26.42M 10-Q · filed 2020-07-30 | $36.49M derived: sum of 3 quarters · filed 2021-02-22 | $46.57M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $12.48M 10-Q · filed 2020-05-06 | $22.54M derived: sum of 2 quarters · filed 2021-02-22 | $32.62M derived: sum of 3 quarters · filed 2021-02-22 | $42.25M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $10.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $20.15M derived: sum of 2 quarters · filed 2021-02-22 | $29.77M derived: sum of 3 quarters · filed 2021-02-22 | $41.31M 10-K · filed 2021-02-22 |
| 2018-09-30 | $10.08M 10-Q · filed 2019-10-22 | $19.70M derived: sum of 2 quarters · filed 2019-10-22 | $31.25M 10-Q · filed 2019-10-22 | $40.29M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $9.62M 10-Q · filed 2019-07-30 | $21.17M 10-Q · filed 2019-07-30 | $30.21M derived: sum of 3 quarters · filed 2020-02-25 | $38.10M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $11.54M 10-Q · filed 2019-04-30 | $20.59M derived: sum of 2 quarters · filed 2020-02-25 | $28.47M derived: sum of 3 quarters · filed 2020-02-25 | $36.47M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $16.93M derived: sum of 2 quarters · filed 2020-02-25 | $24.92M derived: sum of 3 quarters · filed 2020-02-25 | $32.26M 10-K · filed 2020-02-25 |
| 2017-09-30 | $7.88M 10-Q · filed 2018-10-29 | $15.88M derived: sum of 2 quarters · filed 2018-10-29 | $23.21M 10-Q · filed 2018-10-29 | $29.05M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $7.99M 10-Q · filed 2018-07-23 | $15.33M 10-Q · filed 2018-07-23 | $21.16M derived: sum of 3 quarters · filed 2019-02-25 | $28.25M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $7.34M 10-Q · filed 2018-05-01 | $13.17M derived: sum of 2 quarters · filed 2019-02-25 | $20.25M derived: sum of 3 quarters · filed 2019-02-25 | $28.52M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $12.92M derived: sum of 2 quarters · filed 2019-02-25 | $21.18M derived: sum of 3 quarters · filed 2019-02-25 | $28.25M 10-K · filed 2019-02-25 |
| 2016-09-30 | $7.09M 10-Q · filed 2017-11-07 | $15.35M derived: sum of 2 quarters · filed 2017-11-07 | $22.42M 10-Q · filed 2017-11-07 | $29.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $8.26M 10-Q · filed 2017-07-31 | $15.33M 10-Q · filed 2017-07-31 | $22.02M derived: sum of 3 quarters · filed 2018-02-27 | $28.06M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $7.07M 10-Q · filed 2017-05-03 | $13.75M derived: sum of 2 quarters · filed 2018-02-27 | $19.80M derived: sum of 3 quarters · filed 2018-02-27 | $26.74M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $6.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $12.73M derived: sum of 2 quarters · filed 2018-02-27 | $19.67M derived: sum of 3 quarters · filed 2018-02-27 | $25.29M 10-K · filed 2018-02-27 |
| 2015-09-30 | $6.05M 10-Q · filed 2016-11-03 | $12.98M derived: sum of 2 quarters · filed 2016-11-03 | $18.61M 10-Q · filed 2016-11-03 | $25.57M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $6.94M 10-Q · filed 2016-08-03 | $12.56M 10-Q · filed 2016-08-03 | $19.52M derived: sum of 3 quarters · filed 2017-03-01 | $25.05M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $5.62M 10-Q · filed 2016-05-05 | $12.58M derived: sum of 2 quarters · filed 2017-03-01 | $18.11M derived: sum of 3 quarters · filed 2017-03-01 | $23.22M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $12.49M derived: sum of 2 quarters · filed 2017-03-01 | $17.60M derived: sum of 3 quarters · filed 2017-03-01 | $21.93M 10-K · filed 2017-03-01 |
| 2014-09-30 | $5.53M 10-Q · filed 2015-11-05 | $10.63M derived: sum of 2 quarters · filed 2015-11-05 | $14.97M 10-Q · filed 2015-11-05 | $18.90M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $5.10M 10-Q · filed 2015-08-13 | $9.44M 10-Q · filed 2015-08-13 | $13.37M derived: sum of 3 quarters · filed 2016-03-14 | $16.66M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $4.34M 10-Q · filed 2015-05-15 | $8.27M derived: sum of 2 quarters · filed 2016-03-14 | $11.56M derived: sum of 3 quarters · filed 2016-03-14 | $14.17M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $7.22M derived: sum of 2 quarters · filed 2016-03-14 | $9.84M derived: sum of 3 quarters · filed 2016-03-14 | $12.54M 10-K · filed 2016-03-14 |
| 2013-09-30 | $3.29M 10-Q · filed 2014-11-13 | $5.91M derived: sum of 2 quarters · filed 2014-11-13 | $8.61M 10-Q · filed 2014-11-13 | $11.66M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-06-30 | $2.62M 10-Q · filed 2014-08-14 | $5.32M 10-Q · filed 2014-08-14 | $8.37M derived: sum of 3 quarters · filed 2015-03-25 | $10.72M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-03-31 | $2.70M 10-Q · filed 2014-05-09 | $5.76M derived: sum of 2 quarters · filed 2015-03-25 | $8.11M derived: sum of 3 quarters · filed 2015-03-25 | |
| 2012-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $5.40M derived: sum of 2 quarters · filed 2015-03-25 | $8.45M 10-K · filed 2015-03-25 | |
| 2012-09-30 | $2.35M 10-Q · filed 2013-11-25 | $5.39M 10-Q · filed 2013-11-25 | ||
| 2011-12-31 | $2.93M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |